
Rompag 50mg Tablet
Marketer
Hetero Healthcare Limited
Salt Composition
Eltrombopag (50mg)
Overview Rompag 50mg Tablet
Fifty-milligram Rompag tablets are indicated for managing low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection, and also for severe aplastic anemia. This thrombopoietin receptor agonist promotes increased platelet production, thus aiding in hemostasis. Adhere strictly to your physician's prescribed dosage and regimen; it can be taken on an empty stomach. Swallow the tablet whole; avoid crushing, chewing, or breaking it. Report any known allergies to your doctor. Common adverse reactions may include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Report any bothersome side effects to your doctor for potential symptom management strategies. Prior to commencing treatment, disclose any pre-existing medical conditions or concurrent medications to your doctor. Dosage modification may be necessary for patients with hepatic impairment.
Uses of Rompag 50mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; management of critically low blood cell counts.
Major Benefits of Rompag 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg Rompag tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Rompag 50mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Rompag 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg Rompag tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Rompag 50mg Tablet works:
Nplate 50mg tablets function as a thrombopoietin receptor agonist, prompting increased platelet production within the bloodstream. This enhanced platelet count contributes to reduced bleeding risk.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rompag 50mg Tablet may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Rompag 50mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Rompag 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Rompag 50mg Tablet, which can induce dizziness and reduced alertness as side effects.
KidneySAFE IF PRESCRIBED
Rompag 50mg Tablets can be used by patients with kidney disease without altering the dosage. Nevertheless, disclose any kidney conditions to your physician. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Rompag 50mg tablets. Dosage modification of Rompag 50mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Rompag 50mg Tablet :
Omit any missed Rompag 50mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Rompag 50mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Thrombopoietin stimulator |
